Postantibiotic effect of tigecycline against 14 gram-positive organisms

G A Pankuch1, P C Appelbaum

  • 1Department of Pathology, Hershey Medical Center, PA 17033, USA.

Insights

Tigecycline exhibits significant postantibiotic effects (PAEs) and postantibiotic sub-minimum inhibitory concentration effects (PA-SMEs) against various Gram-positive and Gram-negative bacteria, indicating prolonged suppression of bacterial growth after antibiotic exposure.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Tigecycline is a broad-spectrum antibiotic used to treat complex infections.
  • Understanding its postantibiotic effects is crucial for optimizing treatment regimens.

Purpose of the Study:

  • To determine the in vitro postantibiotic effects (PAEs), postantibiotic sub-MIC effects (PA-SMEs), and sub-MIC effects of tigecycline.
  • To evaluate these effects across a panel of 14 Gram-positive and Gram-negative organisms.

Main Methods:

  • In vitro susceptibility testing was performed.
  • Postantibiotic effects (PAEs) were measured by incubating bacteria with tigecycline and then subculturing.
  • Postantibiotic sub-MIC effects (PA-SMEs) were assessed at four times the minimum inhibitory concentration (MIC).

Main Results:

  • Tigecycline demonstrated notable PAEs against Gram-positive bacteria (e.g., Enterococcus: 3.9–6.1 h) and Gram-negative bacteria (e.g., Haemophilus influenzae: 1.1–5.0 h).
  • PA-SMEs were substantial, ranging from 6.7 to >11 h for Gram-positive and 2.3 to >11.3 h for Gram-negative organisms.
  • Variability in effects was observed across different bacterial species.

Conclusions:

  • Tigecycline exhibits significant and prolonged postantibiotic effects, suggesting potential for extended dosing intervals or combination therapies.
  • The observed PAEs and PA-SMEs highlight tigecycline's sustained activity against a range of pathogens.
  • Further clinical studies are warranted to correlate these in vitro findings with clinical outcomes.

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...